The gastric ulcer protective effect of boswellic acids, a leukotriene inhibitor from Boswellia serrata, in rats

Phytomedicine

Volumn 15, Issue 6-7, 2008, Pages 408-415

  Singh, S ^a   Khajuria, A ^a   Taneja, S C ^a   Khajuria, R K ^a   Singh, J ^a   Johri, R K ^a   Qazi, G N ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

Author keywords

Anti inflammatory; Anti ulcer; Boswellia serrata; Boswellic acids; Leukotriene; Ligation

Indexed keywords

11 KETO BETA BOSWELLIC ACID; ACETYL 11 OXO BETA BOSWELLIC ACID; ACETYL BETA BOSWELLIC ACID; ACETYLSALICYLIC ACID; ALCOHOL; BETA BOSWELLIC ACID; BOSWELLIA SERRATA EXTRACT; BOSWELLIC ACID; CIMETIDINE; HYDROCHLORIC ACID; INDOMETACIN; LEUKOTRIENE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BOSWELLIA; CONTROLLED STUDY; DRUG DOSE COMPARISON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMOBILIZATION STRESS; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PYLORUS LIGATION; RAT; STOMACH PROTECTION; STOMACH ULCER; ULCEROGENESIS;

ANIMALS; ANTI-ULCER AGENTS; ASPIRIN; BOSWELLIA; ETHANOL; HEAT; HYDROCHLORIC ACID; INDOMETHACIN; LEUKOTRIENE ANTAGONISTS; LIGATION; MALE; PHYTOTHERAPY; RATS; RATS, WISTAR; STOMACH ULCER; TRITERPENES;

ANIMALIA; BOSWELLIA SERRATA; RATTUS;

EID: 44749088152     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2008.02.017     Document Type: Article

References (27)

1. 4 formation in rat peritoneal neutrophils by an ethanolic extract of gum resin exudates of Boswellia serrata. Planta Med. 57 (1991) 203-207
2. Asano M., Kuribaysshi Y., Ryokawa Y., Hashizume T., and Akashi A. Anti-ulcer effect of 3-[{2-(3,4-dimethoxyphenyl) carbamoyl} methyl]-amino-N-methyl benzamide in experimental gastric and duodenal ulcers. Arzneim-Forsch/Drug Res. 40 1 (1990) 276-281
3. Brunton L.L. Parmacos para control de acidez gastrica e tratamento de ulcerras pepticas. In: Hardman J.G., and Linbud L.E. (Eds). As basis Farmacologicas de Terapeutics (1996), MacGrawHill, Mexico 662-673
4. Desai J.K., Goyal R.K., and Parmar N.S. Pathogenesis of peptic ulcer disease and current trends in therapy. Ind. J. Physiol. Pharmacol. 41 (1997) 03-15
5. Droy-Lefaix M.T. Biology and chemistry of prostaglandins and related eicosanoids. In: Curtis-Prior P.E. (Ed). Prostaglandins (1988), Churchill Livingtone, New York 345-360
6. Goldenberg M.M. Some aspects in the pharmacology of diclonium bromide [2-(3,4 dichloroanilino)quinolizinium bromide] part II: gastric acid - antisecretory and antiulcerogenic action. Arzneim-Forsch/Drug Res. 26 3 (1976) 347-350
7. Goswani S., Jain S., and Santani D. Antiulcer activity of cromakalim against experimentally induced gastric and duodenal ulcers in rats and guinea pigs. J. Pharm. Pharmacol. 49 (1967) 195-199
8. Gupta I.P., Malhotra P., Gupta S., Ludtke R., and Safayhi H. Effect of gum resin of Boswellia serrata in patients with chronic colitis. Planta Med. 67 5 (2001) 391-395
9. Guth P.H., Paulsen G., and Nagata H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rats: effects of prostaglandin cytoprotection. Gastroentrology 87 5 (1984) 1083-1090
10. Hostanska K., Daum G., and Saller R. Cytostatic and apoptotsis-inducing activity of boswellic acids toward malignant cell lines in vitro. Anticancer Res. 22 5 (2002) 2853-2862
11. 2 from LPS stimulated cell line Raw 264.7 cells. Fitotrapia 75 (2004) 261-266
12. Kitagawa H., Fujiwara M., and Osumi Y. Effects of water immersion stress on gastric secretion and mucosal blood flow in rats. Gastroenterology 77 (1979) 298-302
13. Lewis D.A., and Hanson P.J. Anti-ulcer drugs of plant origin. In: Ellis G.P., and West G.B. (Eds). Progress in Medicinal Chemistry (1991), Elsevire Science Publishers, Amsterdam pp. 201-231
14. Mizui T., and Dotuchi M. Effect of polyamines on acid and ethanol-induced gastric lesion in rats. Jpn. J. Pharmacol. 33 (1983) 939-945
15. Morimoto Y., Shimohara K., Oshima S., and Sukamoto T. Effect of the new anti-ulcer agent KB-5492 on experimental gastric mucosal lesions and defensive factors compared to those of terpenone and cimetidine. Jpn J. Pharmacol. 57 (1991) 495-505
16. Pardhy R.S., and Bhattacharaya S.C. β-boswellic acid, acetyl-β-boswellic acid, 11-keto- β-boswellic acid and 11-keto acetyl-β-boswellic acid; four pentacyclic triterpene acids from the gum resin of Boswellia serrata Roxb. Indian J. Chem. 16B (1978) 176-178
17. Parmar N.S., and Desai L.K. A review of the current methodology for the evaluation of gastric and duodenal antiulcer agents. Indian J. Pharmacol. 25 (1993) 120-135
18. Parnaham M.J., and Brune K. Therapeutic control of inflammatory diseases. Agents Actions 21 (1987) 232-234
19. Rainsford K.D. Gastric ulcerogenicity of non-steroidal anti-inflammatory drugs in mice with mucosa sensitized by anolinmimetic treatment. J. Pharm. Pharmacol. 39 (1978) 669-672
20. Safayhi H., Mack T., Sabiraj J., Anazodo M.I., Subramanian L.R., and Ammon H.P.T. Boswellic acids: novel, specific nonredox inhibitors of 5-lipoxygenase. J. Pharmacol. Exp. Ther. 261 3 (1992) 1143-1146
21. Sharma M.L., Kaul A., Khajuria A., Singh S., and Singh G.B. Immunomodulatory activity of boswellic acids (Pentacyclic triterpene acids) from Boswellia serrata. Phytotherapy Res. 10 (1996) 107-112
22. Shay J.P., Komarov S.A., Fels S.S., Meranze D., Grunstein M., and Simpler H. A method for the uniform production of gastric ulceration in the rat. Gastroentrology 5 (1945) 43-61
23. Singh G.B., Singh S., and Bani S. Anti-inflammatory action of boswellic acids. Phytomedicine 3 1 (1996) 81-85
24. Singh S., Khajuria A., Taneja S.C., Johri R.K., Singh J., and Qazi G.N. Boswellic acids: a leukotriene inhibitor also effective through topical application in inflammatory disorders. Phytomedicine (2007) (in press)
25. Wallace J.L., and Granger D.N. The cellular and molecular basis of gastric mucosal defense. FASEB J. 10 (1996) 731-740
26. Whittle B.J. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in rat. Gastroenterology 80 1 (1981) 94-98
27. Zimmerman M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 16 (1983) 109-110